CD8A and cancer: More importantly, the expressions of several inhibitory receptors on the intratumoral CD8+ T cells, including PD-1, CTLA-4, LAG3 and TIM3 were upregulated, resulting in exhausted phenotypes that are frequently observed in cancer patients [48,49].